Author: Lee, Mi Suk; Oh, Jee Youn; Kang, Cheol-In; Kim, Eu Suk; Park, Sunghoon; Rhee, Chin Kook; Jung, Ji Ye; Jo, Kyung-Wook; Heo, Eun Young; Park, Dong-Ah; Suh, Gee Young; Kiem, Sungmin
Title: Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia Document date: 2018_6_26
ID: sl4u8e6e_180
Snippet: • Low-molecular-weight heparin is injected into patients at high risk of venous thromboembolism (level of recommendation: strong, level of evidence: high). • Early ambulation is recommended (level of recommendation: strong, level of evidence: high)......
Document: • Low-molecular-weight heparin is injected into patients at high risk of venous thromboembolism (level of recommendation: strong, level of evidence: high). • Early ambulation is recommended (level of recommendation: strong, level of evidence: high).
Search related documents:
Co phrase search for related documents- early ambulation and high risk: 1
- early ambulation and low molecular weight: 1, 2
- early ambulation and molecular weight: 1, 2
- evidence level and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- evidence level and high strong evidence level: 1, 2, 3, 4, 5
- evidence level and high strong evidence level recommendation level: 1, 2, 3, 4
- evidence level and low molecular weight: 1, 2, 3, 4
- evidence level and molecular weight: 1, 2, 3, 4
- evidence level and recommendation level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- evidence level and strong evidence level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- evidence level and venous thromboembolism: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- high risk and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50
- high risk and molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53
- high risk and recommendation level: 1
- high risk and strong evidence level: 1, 2
- high risk and venous thromboembolism: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- high strong evidence level and recommendation level: 1, 2, 3, 4, 5
- high strong evidence level and strong evidence level: 1, 2, 3, 4, 5
- high strong evidence level recommendation level and recommendation level: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date